Shalabi D - Search Results

1

Immune evasion and current immunotherapy strategies in mycosis fungoides (MF) and Sézary syndrome (SS).

Shalabi D, Bistline A, Alpdogan O, Kartan S, Mishra A, Porcu P, Nikbakht N. Shalabi D, et al. Chin Clin Oncol. 2019 Feb;8(1):11. doi: 10.21037/cco.2019.01.01. Epub 2019 Jan 9. Chin Clin Oncol. 2019. PMID: 30691274 Free article. Review.

2

Skindex-29 scores indicate poor quality of life in early stage mycosis fungoides.

Shalabi D, Kartan S, O'Donnell M, Zaya R, Zhan T, Shi W, Alpdogan O, Porcu P, Nikbakht N. Shalabi D, et al. J Dermatol Sci. 2020 May;98(2):98-101. doi: 10.1016/j.jdermsci.2020.02.010. Epub 2020 Feb 28. J Dermatol Sci. 2020. PMID: 32362434

3

Response to topical corticosteroid monotherapy in mycosis fungoides.

Kartan S, Shalabi D, O'Donnell M, Alpdogan SO, Sahu J, Shi W, Porcu P, Cha J, Nikbakht N. Kartan S, et al. Among authors: shalabi d. J Am Acad Dermatol. 2021 Mar;84(3):615-623. doi: 10.1016/j.jaad.2020.05.043. Epub 2020 May 16. J Am Acad Dermatol. 2021. PMID: 32428610

4

Revisiting Imiquimod for Treatment of Folliculotropic Mycosis Fungoides: A Case Report and Review of the Literature.

Shalabi D, Vadalia N, Nikbakht N. Shalabi D, et al. Dermatol Ther (Heidelb). 2019 Dec;9(4):807-814. doi: 10.1007/s13555-019-00317-2. Epub 2019 Aug 12. Dermatol Ther (Heidelb). 2019. PMID: 31407190 Free PMC article.

5

Determining the role of allergic contact dermatitis in mycosis fungoides.

O'Donnell M, Shalabi D, Gaspari AA, Nikbakht N. O'Donnell M, et al. Among authors: shalabi d. Int J Dermatol. 2020 Jun;59(6):e221-e223. doi: 10.1111/ijd.14770. Epub 2020 Feb 3. Int J Dermatol. 2020. PMID: 32009234 No abstract available.

6

Cutaneous Mucinosis Associated with Beckwith-Wiedemann Syndrome.

Lacey R, Shalabi D, Nikbakht N. Lacey R, et al. Among authors: shalabi d. Skinmed. 2020 Jan 1;18(1):42-44. eCollection 2020. Skinmed. 2020. PMID: 32167456

7

Molluscum contagiosum infection with features of primary cutaneous anaplastic large cell lymphoma.

Shalabi D, Ringe J, Lee JB, Nikbakht N. Shalabi D, et al. Dermatol Online J. 2019 Nov 15;25(11):13030/qt7vp863hz. Dermatol Online J. 2019. PMID: 32045148 Free article.

8

Lymphoplasmacellular mucositis ameliorated by α4β7 integrin inhibitor vedolizumab in a patient with ulcerative colitis.

Shalabi D, Sethi M, Okon L, Debes GF, Lee JB, Nikbakht N. Shalabi D, et al. JAAD Case Rep. 2019 Jul 31;5(8):663-665. doi: 10.1016/j.jdcr.2019.06.002. eCollection 2019 Aug. JAAD Case Rep. 2019. PMID: 31388533 Free PMC article. No abstract available.

9

Linear basal cell nevus with a novel mosaic PTCH1 mutation.

Saeidian AH, Cohen-Nowak A, O'Donnell M, Shalabi D, McGuinn KP, Youssefian L, Vahidnezhad H, Niaziorimi F, Dasgeb B, Kasper DA, Lee JB, Uitto J, Nikbakht N. Saeidian AH, et al. Among authors: shalabi d. Exp Dermatol. 2020 Jun;29(6):531-534. doi: 10.1111/exd.14101. Epub 2020 May 14. Exp Dermatol. 2020. PMID: 32298489

10

Impaired wound healing secondary to bevacizumab.

Ahn JW, Shalabi D, Correa-Selm LM, Dasgeb B, Nikbakht N, Cha J. Ahn JW, et al. Among authors: shalabi d. Int Wound J. 2019 Aug;16(4):1009-1012. doi: 10.1111/iwj.13139. Epub 2019 May 21. Int Wound J. 2019. PMID: 31111622 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

18 results

Search Page